Cao Z, Huang K, Horwitz A F
Department of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, USA.
J Biol Chem. 1998 Nov 27;273(48):31670-9. doi: 10.1074/jbc.273.48.31670.
The alpha5 beta1 integrin is a cell surface receptor for fibronectin implicated in several cellular activities including cell proliferation, differentiation, and migration. The primary site at which the alpha5 beta1 integrin interacts with fibronectin is the RGD (Arg-Gly-Asp) amino acid sequence. In general, the sites on the integrin alpha subunits involved in ligand binding are not well characterized. Based on previous cross-linking studies, sequence alignment, predicted conformation, and intron-exon boundaries, we identified a 144-residue region (positions 223-367) on the alpha5 subunit as a putative binding region and divided it into four subdomains named domains I, II, III, and IV. Chimeric receptors were prepared in which sequences on the alpha5 subunit were exchanged with the corresponding sequences on the alpha6 subunit, which is specific for laminin and does not bind via an RGD sequence. The mutated human alpha5 integrin gene was transfected into CHO B2 cells, which are deficient in alpha5 expression. Only chimeras of domain III or IV express on the cell surface. Both of these chimeras decreased the adhesion, spreading, focal adhesion assembly, and migration on fibronectin. The adhesion of the chimeric receptors to fibronectin remained sensitive to the RGD peptide, and antibodies that inhibit interaction with the fibronectin synergy site and RGD loop remain inhibitory for the chimeras, indicating that our chimeras do not inhibit binding to either the RGD or synergy sites. Finally, the affinity of soluble fibronectin to cells via the alpha5 beta1 receptor decreased only about 3-fold. This decrease is substantially less than the observed effects on migration and spreading, which were not altered by changes in substrate concentration. Thus, the alteration in binding sites does not easily account for the changes in cell spreading and focal adhesion assembly. The tyrosine phosphorylation and focal adhesion assembly that are seen when cells expressing the wild type alpha5 receptor adhere to fibronectin were inhibited in cells expressing the chimeric receptors. Therefore, our results suggest that the chimeras of these domains likely interrupt alpha5-mediated conformational signaling.
α5β1整合素是纤连蛋白的一种细胞表面受体,参与多种细胞活动,包括细胞增殖、分化和迁移。α5β1整合素与纤连蛋白相互作用的主要位点是RGD(精氨酸-甘氨酸-天冬氨酸)氨基酸序列。一般来说,整合素α亚基上参与配体结合的位点尚未得到很好的表征。基于先前的交联研究、序列比对、预测构象和内含子-外显子边界,我们在α5亚基上确定了一个144个残基的区域(第223-367位)作为假定的结合区域,并将其分为四个亚结构域,命名为结构域I、II、III和IV。制备了嵌合受体,其中α5亚基上的序列与α6亚基上的相应序列进行了交换,α6亚基对层粘连蛋白具有特异性,不通过RGD序列结合。将突变的人α5整合素基因转染到缺乏α5表达的CHO B2细胞中。只有结构域III或IV的嵌合体在细胞表面表达。这两种嵌合体都降低了细胞在纤连蛋白上的黏附、铺展、粘着斑组装和迁移。嵌合受体与纤连蛋白的黏附对RGD肽仍然敏感,抑制与纤连蛋白协同位点和RGD环相互作用的抗体对嵌合体仍然具有抑制作用,这表明我们的嵌合体不会抑制与RGD或协同位点的结合。最后,可溶性纤连蛋白通过α5β1受体与细胞的亲和力仅下降了约3倍。这种下降远小于观察到的对迁移和铺展的影响,而迁移和铺展不受底物浓度变化的影响。因此,结合位点的改变不易解释细胞铺展和粘着斑组装的变化。当表达野生型α5受体的细胞黏附于纤连蛋白时出现的酪氨酸磷酸化和粘着斑组装在表达嵌合受体的细胞中受到抑制。因此,我们的结果表明,这些结构域的嵌合体可能会中断α5介导的构象信号传导。